HOME
LUPIN FOUNDATION
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information

THE PHILIPPINES

The Philippines pharmaceutical market is valued at USD 3.9 billion in 2018, reflecting a growth rate of 11.7%. Lupin’s subsidiary, MultiCare Pharmaceuticals Philippines Inc. (MultiCare), a premium branded generics company, generated total revenues of PHP 2,555 million, a decline of 20% compared to the previous year mainly due to the delay of TB tender deliveries to the Department of Health into the next fiscal. MultiCare has a strong presence in Diabetes, Women’s Health, Paediatrics, Respiratory, Central Nervous System and Oncology. MultiCare remains the 5th largest branded generic players in the Philippines.